
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy metabolism, DNA repair and sirtuin signalling. Supplied in research-grade format from a verified batch.
| Purity | ≥99% (LC-MS verified) |
| Form | Lyophilized powder, preservative free |
| Storage | Cool and dry; refrigerate after reconstitution |
| Batch | COA available on request |
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy metabolism, DNA repair and sirtuin signalling. Supplied in research-grade format from a verified batch.
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell, where it functions as the primary electron carrier in redox reactions. It is not a peptide — it is a dinucleotide, built from nicotinamide and adenine riboside units joined by phosphate groups.
Its research prominence comes from two roles: as the redox cofactor driving cellular energy metabolism, and as the required substrate for sirtuins and PARP enzymes, which consume it during DNA repair and gene regulation. Cellular NAD+ declines with age, which is the basis of most longevity research interest.
Supplied for laboratory research use only. Not for human consumption.
NAD+ cycles between oxidised (NAD+) and reduced (NADH) states, carrying electrons through glycolysis, the citric acid cycle and oxidative phosphorylation. The ratio between the two forms is itself a regulated signal.
Sirtuins are NAD+-dependent deacetylases involved in gene regulation and metabolic adaptation. Because they consume NAD+ rather than merely binding it, their activity is directly limited by NAD+ availability — the central observation behind NAD+ research.
PARP enzymes also consume NAD+ during DNA damage response. Extensive DNA damage depletes the cellular pool, creating competition between repair and sirtuin activity that researchers have examined in detail.
A substantial literature compares direct NAD+ with precursors such as nicotinamide riboside and nicotinamide mononucleotide, examining which route most effectively raises intracellular levels.
NAD+ research spans cell culture, animal models and some human studies. It is sold as a research compound here and is not an approved drug.
Concentration is set by the volume of diluent added. For a 500mg vial, 5mL of bacteriostatic water yields 100mg/mL. Calculate the working concentration your protocol requires rather than following a generic figure.
| State | Temperature | Practical shelf life |
|---|---|---|
| Lyophilized, sealed | −20 °C | 24+ months |
| Lyophilized, sealed | 2–8 °C | ~12 months |
| Lyophilized, sealed | Room temperature | Weeks — transit only |
| Reconstituted, bacteriostatic water | 2–8 °C | ~3–4 weeks |
| Reconstituted, sterile water | 2–8 °C | Same session |
Lyophilized peptide is stable enough to survive shipping at ambient temperature, which is why cold-chain courier service is not required for transit. Long-term storage is a different matter — material intended to be held for months belongs in a freezer.
Protect from light, and avoid repeated freeze-thaw cycles. Each cycle causes measurable degradation, so dividing a reconstituted stock into single-use aliquots before freezing is preferable to thawing and refreezing one vial repeatedly.
Every lot is tested by an independent laboratory using two orthogonal methods. HPLC (high-performance liquid chromatography) establishes purity as a percentage of total peptide content, separating the target compound from truncated sequences and synthesis by-products. LC-MS (liquid chromatography–mass spectrometry) confirms molecular identity by mass.
Both matter. Purity alone is insufficient — a 99% pure sample of the wrong compound is still the wrong compound. Together the two tests establish identity and quality, which is why NAD+ is released only after both pass.
The certificate of analysis references the lot number printed on your vial label. Request the COA for your lot at [email protected].
Peer-reviewed studies indexed in PubMed. Each links to the abstract and, where a free copy exists, to the full text. We link primary sources rather than summarising them second-hand.
Compounds studied alongside this one, or acting through related pathways.
Join the Peps Depot mailing list for high-demand restock alerts, subscriber-only offers, release updates and priority access — plus The Friday Brief, our weekly peptide research newsletter covering what actually moved that week. New compounds, new trial data, regulatory shifts.